Myriad Genetics reported $-13800000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Accelerate Diagnostics AXDX:US USD -15705000 2.1M
Agilent A:US USD 471M 60M
Becton, Dickinson and BDX:US USD 926.97M 25.03M
Bio Rad Laboratories BIO:US USD 137.03M 37.67M
Biocept BIOC:US USD -5545000 293K
Bruker BRKR:US USD 138.9M 2.4M
Exact Sciences EXAS:US USD -129927000 21.95M
Fluidigm FLDM:US USD -20775000 9.36M
Johnson & Johnson JNJ:US USD 7.42B 655M
Myriad Genetics MYGN:US USD -13800000 6M
Nanostring Technologies NSTG:US USD -44119000 7.49M
Orasure Technologies OSUR:US USD 15.4M 11.26M
Pacific Biosciences Of California PACB:US USD -84384000 7.41M
Quest Diagnostics DGX:US USD 304M 70M
Repligen RGEN:US USD 45.73M 7.94M
Thermo Fisher Scientific TMO:US USD 2.43B 1.25B
Veracyte VCYT:US USD -3441000 5.43M